SCHEMBL22636632

SCHEMBL22636632

Cc1ccc(-c2ccc(-c3cnsc3C)cc2N)s1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
GFER P55789 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HDAC1 Q13547 3/20 0.33
HDAC2 Q92769 3/20 0.33
HDAC3 O15379 2/20 0.33
TDO2 P48775 1/20 0.32
ESR2 Q92731 1/20 0.32
PTPN11 Q06124 1/20 0.31
WNT1 P04628 1/20 0.31
CLK2 P49760 2/20 0.31
CLK3 P49761 2/20 0.31
DYRK1A Q13627 2/20 0.31
MEN1 O00255 1/20 0.31
MPI P34949 1/20 0.31
KMT2A Q03164 1/20 0.31
PGR P06401 1/20 0.31
IKBKE Q14164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22636776 0.89 FEN1 (0.32) TDO2ESR2
SCHEMBL22648174 0.88 CYP2A6 (0.34) ALDH1A1MAPTHDAC1HDAC2HDAC3
Hydrochloric Acid SCHEMBL30037661 0.87 CYP2A6 (0.33) HDAC1HDAC2HDAC3ESR2PTPN11
SCHEMBL22648208 0.81 KCNH2 (0.45) ALDH1A1NPC1HDAC1HDAC2HDAC3
Hydrochloric Acid SCHEMBL22636634 0.80 KCNH2 (0.44) ALDH1A1NPC1HDAC1HDAC2HDAC3
Hydrochloric Acid SCHEMBL29430632 0.80 KCNH2 (0.44) ALDH1A1NPC1HDAC1HDAC2HDAC3
SCHEMBL22648196 0.79 TDO2 (0.51) ALDH1A1NPC1MAPTGFERHSD17B10
SCHEMBL22636672 0.78 CYP1A2 (0.36) ALDH1A1NPC1MAPTGFERHSD17B10
SCHEMBL22636955 0.78 MAPT (0.39) ALDH1A1MAPTMEN1KMT2APGR
SCHEMBL22648115 0.76 BRD4 (0.36) ALDH1A1NPC1MAPTGFERHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240366595-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS Grey Wolf Therapeutics Limited (GB) 2024-11-07 US disclosed
US-12023333-B2 Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators Grey Wolf Therapeutics Limited (GB) 2024-07-02 US disclosed
US-12023333-B2 Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators Grey Wolf Therapeutics Limited (GB) 2024-07-02 US disclosed
US-20220347176-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS Grey Wolf Therapeutics Limited (GB) 2022-11-03 US disclosed
EP-3966196-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS Grey Wolf Therapeutics Limited (GB) 2022-03-16 EP disclosed
WO-2020225569-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS Grey Wolf Therapeutics Limited (GB) 2020-11-12 WO disclosed
WO-2020225569-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS Grey Wolf Therapeutics Limited (GB) 2020-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240366595-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS CHP1, ERAP1, QSOX1 ALDH1A1 1477/4885NPC1 2957/4885MAPT 4776/4885
US-20220347176-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS ERAP1, CHP1, QSOX1 ALDH1A1 1546/4885NPC1 3102/4885MAPT 4738/4885
US-12023333-B2 Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators ERAP1, CHP1, QSOX1 ALDH1A1 1431/4885NPC1 2881/4885MAPT 4771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.